33J-19601-13252
3 vaccinations
1 coded response
26 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 361 / AL
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Pfizer-BioNTech
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-23
-
2021-03-30
Dose 2 — Pfizer-BioNTech
- 2021-03-30
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Abdominal painAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-13
- 2021-06-29
- 2021-09-28
-
2021-11-20
Dose 3 — Pfizer-BioNTech
-
2022-03-30
Survey response — 12 months, dose 2MedDRA: Gestational hypertension, Pregnancy — Feeling: Good · Be unable to work or attend schoolFree text: Gestational hypertension at the end of my pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-05-21
- 2022-11-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech | |
| 3 | 2021-11-20 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 2
Symptoms: Gestational hypertension at the end of my pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational hypertension | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release